|
(P1726) |
Interleukin-6 and procalcitonin are strong predictors of longterm mortality in patients with cardiogenic shock due to myocardial infarction |
| |
|
T. Beiert, R. Frommold, S. De Maria, M. U. Becher, V. Tiyerili, F. Stöckigt, M. Linhart, G. Nickenig, J. W. Schrickel, R. Andrié (Bonn) |
|
(P1727) |
Cardiovascular Multi-Biomarker Analysis (ST2, GDF-15, suPAR, FABP3 and Fetuin A) in Patients with Acute Myocardial Infarction |
| |
|
M. Lichtenauer, C. Schernthaner, V. Paar, B. Wernly, P. Jirak, R. Pistulli, I. Rohm, C. Jung, H.-R. Figulla, U. C. Hoppe, A. Yilmaz, C. Schulze, D. Kretzschmar (Salzburg, AT; Jena, Düsseldorf, Schmalkalden) |
|
(P1728) |
Cystatin C and cardiovascular mortality in patients admitted to the emergency department with suspected acute coronary syndromes: results from the TRAPID-AMI study |
| |
|
P. Bahrmann, T. Bertsch, E. Giannitsis, M. Christ, B. Hofner, R. H. Christenson, B. Lindahl, C. Müller, TRAPID-AMI (Nürnberg, Heidelberg, Erlangen; Baltimore, US; Uppsala, SE; Basel, CH) |
|
(P1729) |
The role of the tubular biomarker N-Acetyl-beta-D-Glucosaminidase (NAG) in diagnosis of cardio-renal syndrome in patients with chest pain |
| |
|
M. Schlossbauer, S. Stadler, J. Hupf, S. Fenk, M. Fischer, U. Hubauer, L. S. Maier, C. G. Jungbauer (Regensburg) |
|
(P1730) |
Preprocedure C reactive protein predicts outcomes after primary percutaneous coronary intervention |
| |
|
R. Mincu, R. A. Jánosi, D. Vinereanu, T. Rassaf, M. Totzeck (Essen; Bucharest, RO) |
|
(P1731) |
Differences in markers of adiposity, inflammation and oxidative stress in obese patients undergoing coronary artery bypass surgery and their relation to intra- and post-operative complications |
| |
|
K. Buschmann, A. Weber, J. Wrobel, K. Schäfer, A. Daiber, C.-F. Vahl (Mainz) |